PEPE, SARA
 Distribuzione geografica
Continente #
EU - Europa 162
NA - Nord America 80
AS - Asia 27
OC - Oceania 2
AF - Africa 1
Totale 272
Nazione #
US - Stati Uniti d'America 79
IT - Italia 75
IE - Irlanda 44
GB - Regno Unito 9
NL - Olanda 9
SE - Svezia 8
TH - Thailandia 6
FR - Francia 5
IN - India 5
CN - Cina 4
DE - Germania 4
KR - Corea 4
SG - Singapore 4
RU - Federazione Russa 3
FI - Finlandia 2
IQ - Iraq 2
TR - Turchia 2
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
EG - Egitto 1
ES - Italia 1
NZ - Nuova Zelanda 1
UA - Ucraina 1
Totale 272
Città #
Dublin 44
Florence 16
Fairfield 10
Siena 10
Ashburn 7
Los Angeles 7
Bangkok 6
Columbia 5
Milan 5
Nashville 5
Southend 5
Cagliari 4
Houston 4
Salt Lake City 4
San Diego 4
Suwon 4
Wilmington 4
New York 3
Prato 3
Princeton 3
Quarrata 3
Singapore 3
Amsterdam 2
Ann Arbor 2
Baghdad 2
Boardman 2
Cassino 2
Chandler 2
Falconara Marittima 2
Helsinki 2
Istanbul 2
Pietrasanta 2
Seattle 2
Seravezza 2
Shanghai 2
Southwark 2
Utrecht 2
Auckland 1
Cairo 1
Campi Bisenzio 1
Chicago 1
Coimbatore 1
Dunstable 1
Lecce 1
Melbourne 1
Moscow 1
Málaga 1
Palermo 1
Paris 1
Portland 1
Reggio Emilia 1
Rende 1
Richmond 1
Rome 1
San Mateo 1
Toronto 1
Uhlingen-Birkendorf 1
Woodbridge 1
Totale 210
Nome #
The immune checkpoint CD47 as a putative target of the Hedgehog-GLI pathway in melanoma 90
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth 72
ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL 65
Quinolines and Oxazino-quinoline derivatives as small molecule GLI1 inhibitors identified by virtual screening 58
Totale 285
Categoria #
all - tutte 1.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.195


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 6 3 0 5 1 5 14 1
2021/202223 0 0 1 0 0 2 0 0 12 0 3 5
2022/202350 2 4 8 4 3 18 3 2 3 1 2 0
2023/2024159 2 11 4 12 8 30 24 20 0 14 12 22
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 285